Mark Dalton

1.8k total citations
6 papers, 848 citations indexed

About

Mark Dalton is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Mark Dalton has authored 6 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Immunology. Recurrent topics in Mark Dalton's work include Monoclonal and Polyclonal Antibodies Research (3 papers), HER2/EGFR in Cancer Research (2 papers) and T-cell and B-cell Immunology (2 papers). Mark Dalton is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), HER2/EGFR in Cancer Research (2 papers) and T-cell and B-cell Immunology (2 papers). Mark Dalton collaborates with scholars based in United States and United Kingdom. Mark Dalton's co-authors include Andrew C. Chan, Tomohiro Kurosaki, Richard S. Thoma, Richard C. Johnson, Robin R. Johnson, R. James Matthews, Garbiñe Roy, David R. Plas, Matthew L. Thomas and Jeanette T. Pingel and has published in prestigious journals such as Science, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Mark Dalton

6 papers receiving 839 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Dalton United States	6	628	367	240	127	72	6	848
Nicole Brass Germany	15	468 0.7×	566 1.5×	346 1.4×	116 0.9×	58 0.8×	20	1.0k
Tamara R. Hurley United States	9	765 1.2×	568 1.5×	212 0.9×	147 1.2×	110 1.5×	9	1.0k
Zhinan Xia United States	12	668 1.1×	385 1.0×	282 1.2×	38 0.3×	45 0.6×	13	959
Scott D. Gorman United States	16	571 0.9×	479 1.3×	157 0.7×	326 2.6×	51 0.7×	23	1.1k
M. Morra United States	9	918 1.5×	211 0.6×	320 1.3×	48 0.4×	61 0.8×	10	1.4k
Bolen Jb United States	8	238 0.4×	382 1.0×	141 0.6×	132 1.0×	86 1.2×	11	668
Christian Kardinal Germany	16	228 0.4×	560 1.5×	187 0.8×	66 0.5×	60 0.8×	30	920
Craig G. Hall United States	12	568 0.9×	536 1.5×	163 0.7×	115 0.9×	23 0.3×	15	965
Michel Buferne France	21	983 1.6×	329 0.9×	420 1.8×	180 1.4×	41 0.6×	37	1.3k
Silvia Danielian Argentina	11	309 0.5×	159 0.4×	79 0.3×	62 0.5×	68 0.9×	24	498

Countries citing papers authored by Mark Dalton

Since Specialization

Citations

This map shows the geographic impact of Mark Dalton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dalton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dalton more than expected).

Fields of papers citing papers by Mark Dalton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Dalton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dalton. The network helps show where Mark Dalton may publish in the future.

Co-authorship network of co-authors of Mark Dalton

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Dalton. A scholar is included among the top collaborators of Mark Dalton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Dalton. Mark Dalton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Khoo, Saye, Mark Dalton, Alec Bonington, et al.. (2006). Pharmacologic Optimization of Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors (POPIN)-A Randomized Controlled Trial of Therapeutic Drug Monitoring and Adherence Support. JAIDS Journal of Acquired Immune Deficiency Syndromes. 41(4). 461–467. 45 indexed citations

2.

Kong, Guanghui, Mark Dalton, Juliane Bubeck Wardenburg, et al.. (1996). Distinct Tyrosine Phosphorylation Sites in ZAP-70 Mediate Activation and Negative Regulation of Antigen Receptor Function. Molecular and Cellular Biology. 16(9). 5026–5035. 125 indexed citations

3.

Plas, David R., Robin R. Johnson, Jeanette T. Pingel, et al.. (1996). Direct Regulation of ZAP-70 by SHP-1 in T Cell Antigen Receptor Signaling. Science. 272(5265). 1173–1176. 333 indexed citations

4.

Chan, Andrew C., et al.. (1995). Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function.. The EMBO Journal. 14(11). 2499–2508. 314 indexed citations

5.

Schuh, Susan M., Elizabeth P. Newberry, Mark Dalton, & Linda J. Pike. (1994). Mutation of proline-1003 to glycine in the epidermal growth factor (EGF) receptor enhances responsiveness to EGF.. Molecular Biology of the Cell. 5(7). 739–746. 8 indexed citations

6.

Kuppuswamy, Dhandapani, Mark Dalton, & Linda J. Pike. (1993). Serine 1002 is a site of in vivo and in vitro phosphorylation of the epidermal growth factor receptor.. Journal of Biological Chemistry. 268(25). 19134–19142. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact